VEGFA and neoplasm: Nowadays, most of the research focuses on targeting key regulatory nodes such as VEGFA and exploring its joint application with armored CAR-T, immune checkpoint blocking, and metabolic regulatory drugs, aiming at reconstructing the perfusion and immune cell infiltration capacity of tumor areas [141].